David Stewart, MD
Anesthesiology · Snellville, GANPI 1730160144
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 45.6% of the total. Reporting peaked in 2019 at $7,174 and has fallen 96.7% since, to $238 in 2025. Among anesthesiology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 121 payments — averaging $89.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$5K
- Redhill Biopharma Inc.$2K
- Kaleo, Inc.$1K
- Biodelivery Sciences International, Inc.$968
- Boston Scientific$219
- Collegium Pharmaceutical, Inc.$199
- plus $1K from 22 others
What the payments were for
- Consulting fees$1,66015%
- Speaking & faculty fees$5,88054%
- Travel & lodging$7137%
- Food & beverage$2,61024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 45 | $4,953 |
| Redhill Biopharma Inc. | 10 | $1,712 |
| Kaleo, Inc. | 2 | $1,489 |
| Biodelivery Sciences International, Inc. | 7 | $968 |
| Boston Scientific | 3 | $219 |
| Collegium Pharmaceutical, Inc. | 12 | $199 |
| Inari Medical, Inc. | 1 | $189 |
| SPR Therapeutics, Inc | 3 | $146 |
| Stryker | 1 | $141 |
| BD | 1 | $131 |
| Abbott | 3 | $123 |
| Vertex | 3 | $82 |
| Scilex Pharmaceuticals Inc. | 4 | $71 |
| Teva Pharmaceuticals USA, Inc. | 5 | $68 |
| Si-bone, Inc. | 2 | $64 |
| Averitas Pharma Inc. | 2 | $38 |
| Pfizer | 2 | $36 |
| Forte Bio-pharma LLC | 3 | $35 |
| MDD US Operations, LLC | 2 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Chiesi USA, Inc. | 1 | $22 |
| Eagle Pharmaceuticals, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| AbbVie | 1 | $15 |
| Amgen | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LUCEMYRA$4,245
- MOVANTIK$1,660
- EVZIO$1,400
- BELBUCA$880
- FLOWTRIEVER CATHETER, S$330
- CT THROMBECTOMY SYSTEM KIT$330
- GENERAL PAIN MANAGEMENT$175
- HemoSphere$131
- SPRINT PNS System$111
How this compares
$10,863 in reported general payments places this provider in the 95th percentile of 1,137 anesthesiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 83 | $62,736 |
| PercocetOxycodone Hcl/Acetaminophen | 12 | $55,132 |
| MovantikNaloxegol Oxalate | 95 | $50,112 |
| Nucynta ErTapentadol Hcl | 34 | $41,192 |
| OxycontinOxycodone Hcl | 47 | $38,531 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,341 | $36,942 |
| Buprenorphine | 134 | $35,120 |
| Xtampza ErOxycodone Myristate | 51 | $29,397 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,310 | $28,646 |
| NucyntaTapentadol Hcl | 26 | $28,113 |
| Oxycodone Hcl | 576 | $12,085 |
| Tramadol Hcl ErTramadol Hcl | 214 | $11,355 |
| LinzessLinaclotide | 13 | $8,014 |
| Gabapentin | 450 | $7,177 |
| Lidocaine | 44 | $5,658 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er, Xtampza Er, Nucynta | $199 | $161,437194 claims |
| Redhill Biopharma Inc.Movantik | $1,712 | $50,11295 claims |
| AbbVieLinzess | $15 | $8,01413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,137 anesthesiology providers in Georgia.
Other anesthesiology in Snellville
- Margaret HoltzMarietta$622K
- Mark HamiltonAtlanta$351K
- Michael AshmoreAtlanta$214K
- Jessica McCabeJohns Creek$62K
- Stephen KushinsLawrenceville$62K
- Uma ShastriAtlanta$35K
- Jessica McCounRome$34K
- Amit PatelLawrenceville$17K
- Melat GebreAtlanta$16K
- Laura DowneyAtlanta$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.